In addition, we wanted to quantitatively probe for released tumor-specific antigens (HER2 extracellular domain) in the extracellular supernatants and tissue following in vitro and in vivo histotripsy treatment as a function of dose. The gene discussed is ERBB2; the disease is neoplasm.